Pyxis Oncology, Inc. (PYXS)

NASDAQ: PYXS · Real-Time Price · USD

1.150

+0.010 (0.88%)

Jun 20, 2025, 11:54 AM - Market open

Pyxis Oncology Employees

Pyxis Oncology had 44 employees as of December 31, 2024. The number of employees decreased by 6 or -12.00% compared to the previous year.

Employees

44

Change (1Y)

-6

Growth (1Y)

-12.00%

Revenue / Employee

n/a

Profits / Employee

-$2,164,386

Market Cap

71.24M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	44	-6	-12.00%
Dec 31, 2023	50	-25	-33.33%
Dec 31, 2022	75	19	33.93%
Dec 31, 2021	56	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

PYXS News

5 weeks ago - Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
5 weeks ago - Pyxis Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
7 weeks ago - Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC - GlobeNewsWire
2 months ago - Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum - GlobeNewsWire
3 months ago - Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025 - GlobeNewsWire
3 months ago - Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
3 months ago - Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
4 months ago - Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer - GlobeNewsWire